Come up with a name for your new list and we'll add to it:
RAVEN Biotechnologies was acquired by
Macrogenics on July 22, 2008.
Raven biotechnologies is a privately held biotechnology company focused on the simultaneous discovery of novel cell surface drug targets and the antibody therapeutics to regulate them. Raven's integra…